Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker's $63 billion takeover of seed maker Monsanto.
Reuters: Business News, Reuters: Business
Fri, 04/26/2019 - 1:10am
Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker's $63 billion takeover of seed maker Monsanto.